Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-5959 is an effective, specific and cell permeable BRPF1 bromodomain inhibitor (IC50: ~80 nM). The selectivity of GSK-5959 for BRPF1 is <100-fold over a panel of 35 other bromodomains, including BRPF2/3 and BET family bromodomains.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 89.00 | |
25 mg | In stock | $ 159.00 | |
50 mg | In stock | $ 263.00 | |
100 mg | In stock | $ 392.00 | |
200 mg | In stock | $ 573.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 58.00 |
Description | GSK-5959 is an effective, specific and cell permeable BRPF1 bromodomain inhibitor (IC50: ~80 nM). The selectivity of GSK-5959 for BRPF1 is >100-fold over a panel of 35 other bromodomains, including BRPF2/3 and BET family bromodomains. |
Targets&IC50 | BRPF1:80 nM |
Molecular Weight | 394.47 |
Formula | C22H26N4O3 |
CAS No. | 901245-65-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (25.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-5959 901245-65-6 Chromatin/Epigenetic Epigenetic Reader Domain BRPF3 bromodomain Inhibitor inhibit BRD1 BRPF1 GSK 5959 GSK5959 BRPF2 epigenetics inhibitor